Assessment and Treatment of Chronic Wounds Aime D. Garcia, M.D.,CWS - - PowerPoint PPT Presentation

assessment and treatment of chronic wounds
SMART_READER_LITE
LIVE PREVIEW

Assessment and Treatment of Chronic Wounds Aime D. Garcia, M.D.,CWS - - PowerPoint PPT Presentation

Assessment and Treatment of Chronic Wounds Aime D. Garcia, M.D.,CWS Assistant Professor, Baylor College of Medicine Director, Wound Care Clinic and Consult S ervice Michael E. DeBakey Houston VA Medical Center Houston, Texas S peaker


slide-1
SLIDE 1

Assessment and Treatment

  • f Chronic Wounds

Aimée D. Garcia, M.D.,CWS Assistant Professor, Baylor College of Medicine Director, Wound Care Clinic and Consult S ervice Michael E. DeBakey Houston VA Medical Center Houston, Texas

slide-2
SLIDE 2

S peaker Disclosure

 Dr. Garcia has disclosed that neither she nor

members of her immediate family have any actual or potential conflict of interest.

slide-3
SLIDE 3

Obj ectives

  • 1. Review wound types and risk factors.
  • 2. Discuss management priorities and treatment

plans based on proper wound assessment.

slide-4
SLIDE 4

Wound Repair Is a Complex Cellular and Biochemical Response to Inj ury

slide-5
SLIDE 5
slide-6
SLIDE 6

Wound Healing Physiology

Phases of Wound Healing

 Hemostasis (0-3 hours)  Inflammatory (0-3 days)  Proliferative (3-21 days)  Remodeling/Maturation (21 days-1.5 yrs.)

slide-7
SLIDE 7

Factors that Impact Wound Healing

 Nutrition  Medications  Infection  Immobility  Radiation Therapy  Vascular Insufficiency  Chronic Medical Diseases  Aging

slide-8
SLIDE 8

Nutrition in Wound Healing

 CMS

and AHRQ specifically identify nutrition status as a significant risk factor for skin breakdown

 Fibroblasts cannot synthesize collagen without

adequate nutrition

 Wound contraction inhibited by malnutrition  Protein deficiency poses greater risk for infection  Muscle wasting increases risk for pressure inj ury

and wound trauma

slide-9
SLIDE 9

Nutritional Assessment

 Patient History  Physical Exam  Laboratory Testing  Clinical Assessments

slide-10
SLIDE 10

Assessment of Protein Metabolism

 Visceral protein blood levels

 S

erum albumin: 3.3-4.5 g/ dl

 Transferrin: 200-400 mg/ dl  Prealbumin: 20-40 mg/ dl

 Total Lymphocyte counts

 1500-3000 cells/ mm3

slide-11
SLIDE 11

Nutritional S upport

 Treatment Options

 Oral nutritional support  Enteral tube feeding  Parenteral nutrition

 Get a Nutrition consult early in the

management of chronic wounds if nutrition is a concern

slide-12
SLIDE 12

Position of the Academy of Nutrition and Dietetics. J Acad Nut r Diet . 2019

slide-13
SLIDE 13

Medications and Radiation

Compromised Wound Healing

 S

teroids

 Anti-inflammatory drugs  Antimitotic drugs  Radiation therapy

slide-14
SLIDE 14

Wound Infection

 Overgrowth of Microorganisms  Resultant Tissue Destruction

 Local symptoms

 Wound deterioration  Erythema, edema, drainage (purulent), tenderness,

warmth, induration and/ or crepitus  S

ystemic symptoms

 Fever, leukocytosis, confusion, tachycardia,

hypotension, malaise

slide-15
SLIDE 15

https://doi.org/10.1111/j.1742-481X.2007.00388.x

slide-16
SLIDE 16
slide-17
SLIDE 17

Bacterial Burden and Wound Infection

Negative Impact on Wound Healing  Prolongs the inflammatory stage  Induces additional tissue destruction  Delays collagen synthesis  Prevents epithelialization

slide-18
SLIDE 18

Colonization vs. Infection

 Colonization

 Bacteria in wound bed, not affecting the

environment  Critical Colonization

 Wounds with more than 100,000 organisms/ gram

will not heal

 S

uspect bacterial burden if a clean wound shows no improvement after 14 DAYS

  • f topical therapy

 Infection

 Invasion of the soft tissues

slide-19
SLIDE 19

Wound Cultures

 Traditional swab culture detects only surface

bacterial colonization/ contamination

 May not reflect the invasive organism causing

infection  Quantitative Wound Culture recommended for

determining infection

 Documents bacterial burden  Identifies bacteria actually invading wound tissue

slide-20
SLIDE 20

Quantitative Wound Cultures

 Tissue Biopsy  Needle Aspiration  Quantitative S

wab Technique

slide-21
SLIDE 21

Antimicrobial Therapy

 Determination of wound infection  Identification of organism by culture or

gram stain prior to therapy

 Do not use systemic therapy if infection is

local

 Consideration of pharmacology and

toxicology

slide-22
SLIDE 22

Aging S kin

 Decrease dermal-epidermal turnover  Decreased subcutaneous fat deposition  Decreased elastin  Decreased dermal blood flow  Flattening of the rete ridges  Thinning of the skin

slide-23
SLIDE 23

Maj or Types of Wounds

 Pressure Inj uries  Vascular Ulcers

 Arterial Ulcers  Venous S

tasis Ulcers  Neuropathic/ Diabetic Foot Ulcers  Others

 Pyoderma gangrenosum, malignancies,

calciphylaxis

slide-24
SLIDE 24

Definition of Pressure Inj ury

A pressure inj ury is localized inj ury to the skin and/ or underlying tissue usually over a bony prominence, as a result of pressure, or pressure in combination with shear.

International NPUAP-EPUAP Pressure Ulcer Definition

slide-25
SLIDE 25

Epidemiology

 Pressure inj ury in vulnerable populations (elderly

and those with limited mobility) are common

 Acute care – incidence ranges from 0.4%

to 38% with 2.5 million treated annually at cost of $11 billion/ year (1)

  • 1. Pressure ulcers in America. Adv S

kin Wnd Care 2001;14(4): 208 - 215

slide-26
SLIDE 26

Pressure Inj uries

Used to be:

Nursing issue only Physicians “ passive participants”

Currently:

Multidisciplinary: Dietitians Physical therapists Occupational therapists Physicians Nurses Physician Assistants/ Nurse Practitioners Patients Family members

  • Wake. What clinicians need to know. The Permanent e Journal 2010

26

slide-27
SLIDE 27

Pressure Inj uries – What Changed?

 Cost

 1996 – $64 billion(1.2%

  • f health care costs)

 2006 – $11 billion - hospital stays -PU as 1 or 2

dx(1)

 $3500 – >$60,000/ person (depending on stage) (1)

 CMS

 Oct 2008 – withhold reimbursement for HAC

1HCUP 2008 data

27

slide-28
SLIDE 28

CMS : Present on Admission for Acute Care

 Pressure inj uries in acute care are “ reasonably

preventable”

 One of eight original conditions selected as a

present on admission/ hospital-acquired condition (POA/ HAC)

 October 1, 2008 – CMS

denied payment for HAPU

 Hospitals took notice

slide-29
SLIDE 29

CMS Regulations

 Documentation requirements for care

settings

 Influences

 Reimbursement  Citations and fines  Public reporting

slide-30
SLIDE 30

Present on Admission

 S

tage 3 or 4 pressure inj uries

 Location documented on admission by CMS

— defined professional legally responsible for making a medical diagnosis – are eligible for reimbursement

 Physician  MLP (nurse practitioner, clinical nurse specialist,

physician assistant)

slide-31
SLIDE 31

CMS : Unavoidable Pressure Inj uries

 CMS

revised guidance for health care surveyors for LTC

 F Tag 314-pressure inj uries  Identified pressure inj uries=s as most cited condition in

health quality checks (1)

 Variances in survey findings between state and federal

surveyors

 CMS

Goal –To provide more detailed and consistent guidance to surveyors

 Added section on prevention and the definition of

unavoidable pressure ulcer for long-term care

  • 1. Williamson, J Pressure’ s On. http:/ / mcknights.com/ pressures-on/ 107737/ . Pub 3/ 1/ 08
slide-32
SLIDE 32

Unavoidable Pressure Inj ury

 Pressure inj ury develops despite evaluation of

clinical condition and pressure ulcer risk factors

 There needs to be definition and implementation

  • f interventions consistent with needs, goals, and

recognized standards of practice

 Must be monitoring and evaluation of the impact

  • f the interventions

 Must be revision of the approaches to prevention

and treatment as appropriate

Ayello, Lyder, Research and Public Policy Context. Pressure ulcers: prevalence, incidence, an implication for the future. NPUAP , 2012

slide-33
SLIDE 33

Pressure Inj ury S taging

 CMS

requires S taging on their designated assessment forms in LTC and home care

slide-34
SLIDE 34

CMS Mandated Assessment Instruments

 Home Care – OAS

IS C (January 2010) requires documentation POA

 Long-Term Care – Resident Assessment Instrument

(RAI) MDS 3.0 S ection M – (October 2010) requires documentation if S tage II,III, or IV or unstageable were POA

 Inpatient Rehabilitation Facilities and Long-Term

Care Facilities – IRF-P AI (June 2012)

slide-35
SLIDE 35

Common Sites of Pressure Injuries

Occiput (<1% ) Scapula (<1% ) Spine (<1% ) Elbow (<1% )

Sacrum & Coccyx (65%) Trochanter (9%)

Ischium (4% ) Knee (3% ) Tibia (2% )

Heel & Ankle (15%)

slide-36
SLIDE 36

Wound S taging

 Clinicians commonly describe pressure

inj uries using a six-stage classification

system to define the depth of tissue involved

slide-37
SLIDE 37

Wound S taging

The basis for:

 Developing treatment protocols  S

electing reduction support surface

 Obtaining reimbursement for a variety of

wound– related products

slide-38
SLIDE 38

Rules of S taging

 Only used for pressure inj uries  S

tage all pressure inj uries at the deepest level of damage

 Once a pressure inj uries is staged, it remains at that

stage

 Reverse-staging/ back-staging* should never be used

to describe the healing of a pressure inj uries

slide-39
SLIDE 39

CLASSIFICATIONS S tage 1 – Non-blanchable erythema of intact skin

slide-40
SLIDE 40

S tage 2 – Partial thickness skin loss with exposed dermis

slide-41
SLIDE 41
slide-42
SLIDE 42

S tage 3 – Full-thickness loss of skin, in which adipose (fat)

is visible in the ulcer and granulation tissue and epibole (rolled wound edges) are often present. S lough and/ or eschar may be visible.

slide-43
SLIDE 43

S tage 3 Pressure Inj ury

slide-44
SLIDE 44

S tage 4 – Full-thickness skin and tissue loss with exposed or

directly palpable fascia, muscle, tendon, ligament, cartilage or bone in the ulcer. S lough and/ or eschar may be visible.

slide-45
SLIDE 45
slide-46
SLIDE 46

Deep Tissue – Inj ury-Intact or non-intact skin with

localized area of persistent non-blanchable deep red, maroon, purple discoloration or epidermal separation revealing a dark wound bed or blood-filled blister.

slide-47
SLIDE 47
slide-48
SLIDE 48

Unstageable – Full-thickness skin and tissue loss in

which the extent of tissue damage within the ulcer cannot be confirmed because it is obscured by slough or eschar.

slide-49
SLIDE 49
slide-50
SLIDE 50

Arterial Insufficiency

 Peripheral arteriosclerotic occlusive disease is

the most common disorder associated with associated compromised wound healing

 Resultant insufficient arterial perfusion to an

extremity

 Complete or partial arterial blockage may lead to

tissue necrosis and or ulceration

slide-51
SLIDE 51

Arterial Insufficiency/ Ulceration

 Risk Factors:

 Peripheral Vascular Disease (PVD)  Diabetes Mellitus  Hypertension  Advanced age  S

moking

slide-52
SLIDE 52

Arterial Ulcer Location

 Distal toes  Heel  Pretibial area  Lateral malleolus

slide-53
SLIDE 53

Arterial Ulcer Characteristics

 Painful ulceration  Pale wound bed lacking granulation  Minimal drainage – desiccated and dry  Appearance – “ punched out”  May be necrotic  Peri-wound skin pale

slide-54
SLIDE 54
slide-55
SLIDE 55

Arterial Assessment

Clinical Assessment:

 Weak/ absent pulses  Pain and Claudication  Dependent rubor  Elevation pallor  Absence of leg hair  S

kin shiny, dry, pale

 Thickened nails

Vascular Assessment:

 ABI <0.8  TCOM  CT angio if symptomatic  Referral for intervention- IR, Cardiology, Vascular surgery

slide-56
SLIDE 56

Arterial Ulcer Management

 Maximize blood flow and tissue perfusion

 Refer early if symptomatic

 Treatment Options:

 S

urgical revascularization

 Angioplasty  Pharmacotherapy agents  Lifestyle changes

slide-57
SLIDE 57

Arterial Ulcer Management Optimize the

Wound Environment

 Topical dressings

 If dry, keep dry  If wet/ unstable, moist dressings

 Autolytic debridement  Moist wound healing

 Observe for infection

 If poor blood flow, antibiotic usefulness may be limited  Topical antimicrobial therapy if no s/ s of infection

 Judicious debridement

 May not have vascular ability to support healing

 No sharp debridement  Other types of debridement can be used if wound bed is

unstable  May potentiate the tissue ischemia

slide-58
SLIDE 58

Venous Insufficiency

 1%

  • f the population

 3.5%

  • f persons over 65 yr of age

 Recurrence rate of 70%  Venous ulcers account for 90%

  • f all chronic wounds
  • n the lower leg

 Result from disorders of the

deep venous system

slide-59
SLIDE 59

Venous Ulcers

 Predisposing factors:

 Thrombophlebitis  Deep Vein Thrombosis (DVT)  Prior pregnancy  Leg trauma  Cardiac disease  Poor nutrition  Absence of/ or poor calf muscle pumps

slide-60
SLIDE 60

Venous Ulcer

Location/ Characteristics

 Most common location

 Medial aspect of leg superior to medial malleolus

 Exudation varies  Degree of pain varies greatly from painless to

extremely painful

 Irregular wound margins  Granulation tissue usually present

slide-61
SLIDE 61

Venous Ulcer Assessment

 Edema  Hemosiderin deposits  Pulses present  “ Ankle Flaring”  Lipodermatosclerosis  Dermatitis  S

carring from previous ulcer

slide-62
SLIDE 62

Venous Ulcer Management

 Goal:

 Reduce venous hypertension and improve venous

return  Treatment Options

 Elevation of legs  Topical Management/ Dressings  Compression therapy  S

urgical ligation of incompetent perforators

slide-63
SLIDE 63

Venous Ulcer Management

Optimize Wound Environment

 Compression therapy

 Increases interstitial tissue

pressure, which eliminates the leakage of fluid from capillaries into tissues and supports reabsorption of fluid back into blood stream

slide-64
SLIDE 64

Diabetic Foot Ulcers

 Plantar ulcers (metatarsal heads) caused by

combination of neuropathy and small vessel vascular insufficiency, leading to ischemia in the soft tissues compressed against bone

 Hyperglycemia impairs leukocyte function and

collagen synthesis

slide-65
SLIDE 65

Diabetic Foot Ulcer

 Affect more than 1 million patients at some

point in their lifetime

 Diabetic patients form the single largest

group of non-traumatic amputations in the United S tates

 50%

  • f patients with amputation of a leg

due to Diabetes will have the other leg amputated within 2 years.

slide-66
SLIDE 66

Diabetic Foot Ulcer

 Predisposing Factors

 Peripheral vascular disease  Peripheral neuropathy

 Altered or complete loss of sensation in foot/ leg  Lose all sharp-dull discrimination  Cuts or trauma can go unnoticed

slide-67
SLIDE 67

Diabetic Ulcer Characteristics

 Painless  Even wound margins with propensity to

form callous

 Deep wound bed  Granular tissue

slide-68
SLIDE 68

Diabetic Ulcer Assessment

 Neuropathy

 Diminished or no sensation in foot

 Foot deformities  Arterial evaluation

slide-69
SLIDE 69

Charcot Foot Deformity

 Arterial vascular compromise and bone infarcts

leading to midfoot micro fractures result in collapse of normal boney architecture

 Disfigurement, swelling, and abnormal bony

prominences  Plantar ulcerations with necrosis and infection

slide-70
SLIDE 70

Diabetic Ulcer Management

 Control serum glucose levels  Offloading & Orthotics  Absorb drainage  Maintain a moist wound

environment

 Monitor for infection  Debride necrotic tissue and

hyperkeratotic rim

slide-71
SLIDE 71

Documentation

 Must take systematic approach

 Ulcer measured from head-to-toe  Length X Width X Depth in centimeters  Assess periwound tissues, wound bed and level

and type of exudate

 Evaluate undermining  Cannot “ backstage”

slide-72
SLIDE 72

UNDERMINING

 Dead S

pace

 Appropriate dressing  Risk of infection

slide-73
SLIDE 73

General Principles of Wound Management

 Reduce/ eliminate the cause  Provide systemic support  Appropriate topical therapy

slide-74
SLIDE 74

Reduce/ Eliminate the Cause

 Pressure  S

hear

 Friction  Moisture  Circulatory impairment  Neuropathy

slide-75
SLIDE 75

Provide S ystemic S upport

 S

upport fluid and nutritional intake

 Gain control of systemic factors affecting

wound healing

slide-76
SLIDE 76

S ibbald G, et al. Adv S kin Wound Care. 2007 Jul; 20(7):390-405

slide-77
SLIDE 77

Conclusion

 Identification of the type of wound guides

management

 Good documentation is important for

communication

 Wound bed preparation is the cornerstone of

wound healing